Treace Medical Concepts (Treace Medical Concepts) EV-to-Revenue : 1.65 (As of Jun. 21, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Treace Medical Concepts EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Treace Medical Concepts's enterprise value is $323.5 Mil. Treace Medical Concepts's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $196.0 Mil. Therefore, Treace Medical Concepts's EV-to-Revenue for today is 1.65.

The historical rank and industry rank for Treace Medical Concepts's EV-to-Revenue or its related term are showing as below:

TMCI' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.18 Med: 9.28 Max: 28.44
Current: 1.65

During the past 5 years, the highest EV-to-Revenue of Treace Medical Concepts was 28.44. The lowest was 1.18. And the median was 9.28.

TMCI's EV-to-Revenue is ranked better than
69.09% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: 3.01 vs TMCI: 1.65

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-21), Treace Medical Concepts's stock price is $5.90. Treace Medical Concepts's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $3.18. Therefore, Treace Medical Concepts's PS Ratio for today is 1.86.

Treace Medical Concepts EV-to-Revenue Historical Data

The historical data trend for Treace Medical Concepts's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Treace Medical Concepts EV-to-Revenue Chart

Treace Medical Concepts Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

9.89

8.93

3.92

Treace Medical Concepts Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial													9.31	9.01	4.33	3.92	3.92

Competitive Comparison of Treace Medical Concepts's EV-to-Revenue

For the Medical Devices subindustry, Treace Medical Concepts's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Treace Medical Concepts's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Treace Medical Concepts's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Treace Medical Concepts's EV-to-Revenue falls into.

Treace Medical Concepts EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Treace Medical Concepts's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	323.475	/	196.031
	=	1.65

Treace Medical Concepts's current Enterprise Value is $323.5 Mil.
Treace Medical Concepts's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $196.0 Mil.

Treace Medical Concepts (NAS:TMCI) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Treace Medical Concepts's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	5.90	/	3.18
	=	1.86

Treace Medical Concepts's share price for today is $5.90.
Treace Medical Concepts's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.18.

Treace Medical Concepts EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Treace Medical Concepts's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Treace Medical Concepts (Treace Medical Concepts) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Treace Medical Concepts Inc (NAS:TMCI) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Palmetto Park Place, Ponte Vedra, FL, USA, 32081

Website

https://www.treace.com

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.

Executives

F Barry Bays	director
Betsy Hanna	director	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE RD #150, PONTE VEDRA BEACH FL 32081
Deepti Jain	director	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sean F. Scanlan	officer: See Remarks	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
James T Treace	director	117 BRISTOL PLACE, PONTE VEDRA BEACH FL 32082
Richard W Mott	director	1221 CROSSMAN AVENUE, SUNNYVALE CA 94089
Thomas E Timbie	director
Daniel E. Owens	officer: Chief HR Officer	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Scot Michael Elder	officer: *See "Remarks"	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Mark Hair	officer: Chief Financial Officer	C/O RESTORATION ROBOTICS, INC., 128 BAYTECH DRIVE, SAN JOSE CA 95134
Aaron Berutti	officer: Sr. VP, Sales	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
John T. Treace	director, 10 percent owner, officer: Chief Executive Officer	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Lance A Berry	director	5677 AIRLINE ROAD, ARLINGTON TN 38002
Jane E Kiernan	director	525 W ROSCOE, CHICAGO IL 60657
John R Treace	director	5677 AIRLINE RD, ARLINGTON VA 38002